This brand name is authorized in Lithuania, Romania.
The drug GINKOR FORT contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
19FUJ2C58T - GINKGO
|
|
The exact mechanism of action of ginkgo biloba is not known. Human pharmacological data show increased EEG vigilance in geriatric subjects, reduction in blood viscosity and improved cerebral perfusion in specific areas in healthy men (60-70 years) and reduction in platelet aggregation. Additionally, vasodilating effects on forearm blood vessels causing increased regional blood flow are shown. |
|
2
|
UNII
7Y4N11PXO8 - TROXERUTIN
|
|
The pharmacodynamic effects of oxerutins have been demonstrated in different in vitro and in vivo studies. At the cellular level the capability of oxerutins to protect the vascular wall from the oxidative attack of activated blood cells and its affinity to the endothelium of capillaries and venoles could be shown. |
|
3
|
UNII
XB3RM40HIR - HEPTAMINOL HYDROCHLORIDE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C05CA54 | Troxerutin, combinations | C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CA Bioflavonoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| LT | Valstybinė vaistų kontrolės tarnyba | 1007663 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W63052001, W63052002 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.